Fundz

Real-time funding, M&A, exec moves & hiring — the signals that move deals

More real-time opportunities that match your ICP — every funding, M&A, and exec move the moment it breaks, with the verified contacts to reach out first.

The funding market, moving in real timeBook a DemoStart with Pro — $79/mo
Loading live signals…

Funding, M&A, exec moves & hiring — every signal Fundz sees, the moment it happens. See who’s in your market, who to reach, and why now.

N-Zyme Biomedical has closed a US$4.6 million Series A financing round to advance clinical development. This funding will support their ongoing research and development efforts.

PRIVATEJul 21, 20266 days ago

Amount Raised

$4.6 Million

Round Type

Series A

BiotechnologyHealth Care

Description

N-Zyme Biomedical has successfully closed a Series A financing round, raising US$4.6 million. The funds will be allocated towards the advancement of clinical development projects. This financing is crucial for enhancing their research capabilities. The company aims to make significant progress in the biotech sector.

Company Information

Company

N-Zyme Biomedical

About

N-Zyme Biomedical is a biotech company focused on the clinical development of innovative therapies. The company aims to advance treatments through its research and development efforts. They have recently closed a significant funding round to support these initiatives.

Related People

Suggested for you
1 contact

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for N-Zyme Biomedical's next move

Learn about Strategic plan

Funding Insights

Based on industry data
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months
Monthly burn rate benchmark
47% of Series A startups spend $400k or more per month on operations

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.

Watching N-Zyme Biomedical? See every signal — funding, hires, M&A, contracts, sentiment.

Book a demoChoose your plan